A new study has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing ...

Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...

The CHMP recommends conditional marketing authorization for Duvyzat to treat Duchenne muscular dystrophy in patients aged 6 ...

The REVERSE-IT trial showed bentracimab effectively reversed the effects of ticagrelor, restoring platelet function with ...

A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at ...

Novartis raised its 2025 outlook after high demand for key drugs drove first-quarter profit and sales above expectations, becoming the first among peers to lift forecasts this quarter despite looming ...

In the future, this drug could help prevent second heart attacks in patients who are at high risk. It could also lower the ...

Human Platelet Lysate Market is projected to grow significantly through 2035, Driven by demand for stem cell therapy and regenerative medicine ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

The Drug Enforcement Administration encourages everyone to turn in their unused and unwanted prescriptions on Saturday, April ...

A group of Australian pet owners who say their dogs suffered adverse effects or died after receiving an osteoarthritis ...

Could you offer any general advice on how patients should weigh the risks versus benefits when they are prescribed a drug ...